o NoneEntity Type
0001490596
GoviEx Uranium, Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 GoviEx Uranium Inc.
Jurisdiction of Incorporation/OrganizationBRITISH COLUMBIA, CANADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 GoviEx Uranium Inc. 
Street Address 1Street Address 2
 WORLD TRADE CENTRE, 999 CANADA PLACE SUITE 654
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 VANCOUVER BRITISH COLUMBIA, CANADA V6C 3E1 604-689-8765 



3. Related Persons
Last NameFirst NameMiddle Name
FriedlandGovind
Street Address 1Street Address 2
World Trade Centre, 999 Canada PlaceSuite 654
CityState/Province/CountryZIP/Postal Code
VancouverBRITISH COLUMBIA, CANADAV6C 3E1
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
MajorDaniel
Street Address 1Street Address 2
World Trade Centre, 999 Canada PlaceSuite 654
CityState/Province/CountryZIP/Postal Code
VancouverBRITISH COLUMBIA, CANADAV6C 3E1
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
WangLei
Street Address 1Street Address 2
World Trade Centre, 999 Canada PlaceSuite 654
CityState/Province/CountryZIP/Postal Code
VancouverBRITISH COLUMBIA, CANADAV6C 3E1
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RomoRodrigo
Street Address 1Street Address 2
World Trade Centre, 999 Canada PlaceSuite 654
CityState/Province/CountryZIP/Postal Code
VancouverBRITISH COLUMBIA, CANADAV6C 3E1
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance x Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
x Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-02-13 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 877150 USD o Indefinite
Total Amount Sold $ 377150 USD 
Total Remaining to be Sold $ 500000 USD o Indefinite
 
Clarification of Response (if Necessary)
 Sec 13 is the price of the Units (3,333,334 at C$0.15) converted to US$ at $1C to $0.7543 US, plus the aggregate exercise price (US $0.15) of the warrants forming part of the Units. There is no guarantee the warrants will be exercised.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Goviex Uranium (QB) (USOTC:GVXXF)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024 Goviex Uranium (QB) 차트를 더 보려면 여기를 클릭.
Goviex Uranium (QB) (USOTC:GVXXF)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024 Goviex Uranium (QB) 차트를 더 보려면 여기를 클릭.

Goviex Uranium Inc. News

Goviex Uranium Inc (QB) (OTC 시장)의 실시간 뉴스: 최근 기사 0

More Goviex Uranium Inc. News Articles